Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 22, 2021 19:22 ET | Source: Telix Pharmaceuticals Limited

First Patient Dosed in Clinical Study of TLX250-CDx in Bladder Cancer

MELBOURNE, Australia, June 22, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that a first patient has been dosed in a Phase I study of...
November 28, 2018 18:17 ET | Source: Telix Pharmaceuticals Limited

テリックスと日本メジフィジックスがアクチニウム標識腎癌治療薬の開発を目指した技術提携契約を締結

MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（本社：オーストラリアメルボルン、CEO：Dr. Christian...
November 28, 2018 18:17 ET | Source: Telix Pharmaceuticals Limited

Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics

MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
August 23, 2018 19:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals, University of Melbourne and Peter Mac to Collaborate on Colorectal Cancer

MELBOURNE, Australia, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”) has today announced a research collaboration with the University of Melbourne...